Expression of PDGF, IGF-II, bFGF and TGF-β1 in pulmonary adenocarcinoma

Pathology Research and Practice

Volumn 192, Issue 11, 1996, Pages 1113-1120

  Takanami, I ^a,c   Imamuma, T ^a   Hashizume, T ^b   Kikuchi, K ^b   Yamamoto, Y ^a   Yamamoto, T ^a   Kodaira, S ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b Kanagawa Hospital   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Basic fibroblast growth factor; Insulin like growth factor II; Platelet derived growth factor; Pulmonary adenocarcinoma; Transforming growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; PARAFFIN; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN B; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; TISSUE SECTION;

EID: 0030514016     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80028-8     Document Type: Article

References (41)

1. Ariad LS, Bezwoda WR (1991) Platelet-derived growth factor (PDGF) in plasma of breast patients: Correlation with stage and rate of progression. Breast Cancer Res Treat 20: 11-17
2. Autoniades HN, Owen AJ (1988) Growth factors and regulation of cell growth. Annu Rev Med 33: 445-463
3. BetsholtzC, BerghJ, BywaterM, etal. (1981) Expression of multiple growth factors in a human lung cancer cell line. Int J Cancer 39: 502-507
4. Eguchi J, Nomata K, Kanda S, et al. (1992) Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma. Biochem Biophys Res Commun 183: 937-944
5. Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Gold LI, Korc M (1993) Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival . Gastroenterology 305: 1846-1856
6. Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA (1992) Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res 52: 6949-6952
7. Haselbacher GK, Irminger JC, Zapf J, Ziegler WH, Humble RE (1987) Insulin-like factor in human adrenal pheochromocytomas and Wilm's tumors: Expression at the mRNA and protein level. Proc Natl Acad Sci USA 84: 1104-1106
8. Havemann K, Rotsch M, Schoneberger HJ, Erbil C, Jacques G (1990) Growth regulation by insulin-like growth factor in lung cancer. J Steroid Biochem Mol Biol 37; 877-882
9. Henriksen K, Funa K, Wilender E, Bockstrom T, Ridderhaim H, Oberg K (1993) Expression of prognostic significance of platelet-derived growth and its receptors in epithelial ovarian neoplasms. Cancer Res 53: 4550-4554
10. Hirayama D, Fujimori T, Satonaka K, et al. (1992) Immunohistochemical study of epidermal growth factor and transforming growth factor-β in the penetrating type of early gastric cancer. Hum Pathol 23: 681-685
11. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 39: 577-580
12. Jasani B, Wyllie FS, Wrigrt PA, Lemoine NR, Williams ED, Wynford-Thomas D (1990) Immunocytochemically detectable TGF-β is associated with malignancy in thyroid epithelial neoplasia. Growth Factors 2: 149-155
13. Johnson MD, Federspiel CF, Gold LI, Moses HL (1992) Transforming growth factor-β and transforming growth factor β receptor expression in human meningioma cell. Am J Pathol 341: 633-642
14. Kaiser U, Schardt C, Ebandscheidt D, Wollmer E, Havemann K (1993) Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer. J Res Clin Oncol 119: 665-668
15. Kurobe M, Takai Y, Ezawa H, Hayashi K (1993) Increased level of basic fibroblast growth factor (bFGF) in sera of patients with malignant tumors. Horm Metab Res 25: 395-396
16. Lambert S, Vivario J, Boniver J, Gol-Winker A (1990) Abnormal expression and structural modifications of the insulin-like growth factor II gene in human colorectal tumors. Int J Cancer 46: 405-410
17. Macchiarini P, Fontanini G, Hardin MJ, Squatini F, Angeletti CA (1992) Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340: 145-146
18. Massague J (1987) The TGF-β family of growth and differentiation factors. Cell 49: 437-438
19. Morgan DO, Edman JC, Standing DN, Fried VA, Smith MC (1987) Insulin-like growth factor II receptor as a multi-function binding protein. Nature 329: 301-307
20. Mountain CF (1986) A new international staging system for lung cancer. Chest 89S: 225S-233S
21. Nguyen M, Watanabe H, Budson AE, Richie JP, Folkman J (1983) Elevated angiogenic peptide basic fibroblast growth factor in urine bladder cancer patients. J Natl Cancer Inst 85: 241-242
22. Qi CF, Liscia DS, Normanno N, et al. (1994) Expression of transforming growth factor a, amphioregulin and cripto-1 in human breast carcinomas. Br J Cancer 69: 903-910
23. Railo MJ, Smitten KV, Pekonen F (1994) The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients. Eur J Cancer 30A: 309-311
24. Safi AMB, Sadmi MBS, Martinet N, et al. (1992) Presence of elevated levels of platelet-derived growth factor (PDGF) in lung adenocarcinoma pleural effusion. Chest 102: 204-207
25. Samuels V, Barret JM, Bockman S, Pantazis CG, Allen MB (1989) Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. Am J Pathol 134: 892-902
26. Scott J, Cowell J, Robertson ME, et al. (1985) Insulin-like growth factor-II gene expression in Wilm's tumor and embryonic tissues. Nature 317: 260-262
27. Seymour L, Dajee O, Bezwoda WR (1993). Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer. Breast Cancer Res Treat 26: 247-252
28. Soderdahl G, Betsholtz C, Johnsson A, Nilsson K, Bergh J (1988) Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small-cell human lung carcinoma lines. Int J Cancer 41: 636-641
29. Steiner MS, Barrack ER (1992) Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol 6: 15-25
30. Tanimoto H, Yoshida K, Yokozaki H, et al. (1991) Expression of basic fibroblast growth factor in human gastric carcinomas. Virchows Arch B Cell Pathol 61: 263-267
31. Tateishi M, Ishida T, Mitudomi T, Sugimachi K (1991) Prognostic implication of transforming growth factor a in adenocarcinoma of the lung. - an immunohistochemical study. Br J Cancer 63: 130-133
32. Tateishi M, Ishida T, Mitsudomi T, Kaneko S, Sugimachi K (1990) Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res 50: 7077-7080
33. Tateishi M, Ishida T, Mitsudomi T, Kaneko S, Sugimachi K (1991) Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 27: 1372-1375
34. Tessler S, Neufeld G (1990) Basic fibroblast growth factor accumulates in the nuclei of various bFGF producing cell types. J Cell Phys 145: 310-331
35. The Japan Lung Cancer Society (1995) General Rule for Clinical Pathological Record of Lung Cancer. Kinbara Pr., Tokyo
36. Travis WD, Travis LB, Devesa SS (1995) Lung cancer. Cancer 75: 191-202
37. Valaitis J, Warren S, Gamble D (1981) Increasing incidence of adenocarcinoma of the lung. Cancer 47: 1042-1047
38. Walker RA, Dearing SJ (1992) Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinoma of the breast. Eur J Cancer 28: 641-644
39. Yamanaka Y, Friess H, Buchler M, Beger HG, Uchida E, Kobrin MS, Korc M (1993) Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 53: 5289-5296
40. Yasui W, Hata J, Yokozaki H, Nakatani H, Ochiai A, Ito H, Tahara E (1988) Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer 41: 211-217
41. Yee D, Cullen KJ, Paik S, et al. (1988) Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48: 6691-6696